Dr. MiltieAtlas by Dr. Miltie™Healthcare Grant Intelligence
Active - Solution Summary stageAtlas Opportunity Score 52/100

HHS ARPA-H UNIQUE Quantum Biomedical Imaging — ARPA-H-SOL-26-162

FundingARPA-H anticipates multiple Other Transaction agreements. Public program materials do not state a single award amount; review the controlling ISO and attachments for funding, milestone, cost, and payment terms.
DeadlineSolution Summary due October 30, 2026 at 11:59 PM ET; Full Proposal due December 15, 2026 at 11:59 PM ET.
Last verifiedSeptember 30, 2026
Required next actionReview ARPA-H-SOL-26-162 and the current official materials, confirm the proposed team addresses the program's listed technical requirements, and submit the required Solution Summary by October 30, 2026 at 11:59 PM ET. The Full Proposal deadline is December 15, 2026 at 11:59 PM ET.

Broad Eligibility

ARPA-H seeks cross-disciplinary performer teams. Exact proposer eligibility, exclusions, registrations, teaming rules, award instrument, and participation requirements are controlled by ARPA-H-SOL-26-162 and its attachments on SAM.gov.

Atlas Analysis

Atlas Opportunity Score 52/100. UNIQUE is a high-risk, high-reward biomedical imaging research opportunity centered on quantum-derived observables and their integration with anatomical, functional, and molecular imaging. ARPA-H seeks cross-disciplinary teams spanning quantum science, radiological sciences, biomedical imaging, engineering, materials science, computational modeling, and AI-based reconstruction and interpretation.

The HHS Advanced Research Projects Agency for Health (ARPA-H) has opened the UNifying Imaging with QUantum Entanglement (UNIQUE) Innovative Solutions Opening, Notice ID ARPA-H-SOL-26-162. UNIQUE seeks a new biomedical-imaging paradigm that combines anatomical, functional, molecular, and quantum-derived information so disease-related biological changes can be detected and interpreted earlier than with current imaging approaches.

The program has two technical areas. TA1 Imaging Core focuses on the physical systems needed to generate and measure quantum observables in clinically relevant settings, including quantum-correlated photon production and collection, engineered source materials and nanomaterials, quantum-aware detectors, and methods that use decoherence and correlation loss as possible sources of biological contrast. TA2 Quantum AI Interpretation and Fusion focuses on physics-informed AI, quantum-aware reconstruction, multimodal data fusion, uncertainty quantification, and real-time interpretation of multidimensional quantum observables.

A Solution Summary is required before a full proposal. Solution Summaries are due October 30, 2026 at 11:59 PM ET, and Full Proposals are due December 15, 2026 at 11:59 PM ET. ARPA-H anticipates multiple Other Transaction agreements. The controlling solicitation and attachments are maintained on SAM.gov, and submission is through the ARPA-H Solutions portal. An optional Proposers’ Day is scheduled for October 15, with registration required by October 13 under separate Special Notice ARPA-H-SN-26-162.

Atlas Opportunity Score: 52/100. N9+ Fit: 8/100. UNIQUE has substantial medical-imaging and AI relevance, but the core requirements are quantum science, radiological sciences, biomedical imaging, engineering, materials science, and quantum-aware computation. Dr. Miltie should not be advanced as a prime or technical contributor without documented capability directly relevant to those disciplines.

Source verificationOfficial government source · arpa-h.govAtlas last verified this record September 30, 2026. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗